Susquehanna International Group, LLP Seelos Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.16 - $1.64 $8,295 - $85,024	51,844 Added 97.73%	104,892 $18,000
Q2 2023 Aug 11, 2023	BUY	$0.66 - $1.22 $35,011 - $64,718	53,048 New	53,048 $63,000
Q4 2022 Feb 14, 2023	SELL	$0.66 - $259.46 $104,636 - $41.1 Million	-158,540 Reduced 70.19%	67,331 $45,000
Q3 2022 Nov 14, 2022	SELL	$0.65 - $278.68 $177,147 - $75.9 Million	-272,534 Reduced 54.68%	225,871 $233,000
Q2 2022 Aug 15, 2022	BUY	$0.51 - $0.93 $53,779 - $98,068	105,450 Added 26.84%	498,405 $339,000
Q1 2022 May 16, 2022	BUY	$0.84 - $1.71 $157,868 - $321,375	187,939 Added 91.67%	392,955 $329,000
Q4 2021 Feb 14, 2022	BUY	$1.59 - $2.38 $133,874 - $200,391	84,198 Added 69.69%	205,016 $334,000
Q3 2021 Nov 15, 2021	BUY	$1.69 - $2.89 $48,127 - $82,301	28,478 Added 30.84%	120,818 $291,000
Q2 2021 Aug 11, 2021	SELL	$2.64 - $6.32 $1.19 Million - $2.84 Million	-449,047 Reduced 82.94%	92,340 $244,000
Q1 2021 May 17, 2021	BUY	$1.35 - $4.99 $730,872 - $2.7 Million	541,387 New	541,387 $2.7 Million
Q4 2019 Feb 14, 2020	SELL	$0.72 - $1.52 $13,117 - $27,692	-18,219 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$0.92 - $2.15 $16,761 - $39,170	18,219 New	18,219 $17,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $312M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.